PRO MEDICUS LIMITED (PME)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

PME - PRO MEDICUS LIMITED
FNArena Sector :
Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH
FNArena Sector : Medical Equipment & Devices
Year End: June
Pro Medicus is an imaging IT company providing a range of radiology software and services, medical accounting and clinical reporting to the health care sector. Founded in 1983, the company listed on the ASX in 2000.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$41.34
16 May |
OPEN $40.86 |
HIGH $42.29 |
156,944 LOW $40.58 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
ELX . PGC . AHZ . COH . FPH . IPD . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . AT1 . CBL . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY20 Actual |
FY21 Actual |
FY22 Forecast |
FY23 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 29.6 | 42.8 | xxx |
DPS (cps) | xxx | 15.0 | 20.2 | xxx |
EPS Growth | xxx | 33.4% | 44.3% | xxx |
DPS Growth | xxx | 25.0% | 34.7% | xxx |
PE Ratio | xxx | N/A | 93.4 | xxx |
Dividend Yield | xxx | N/A | 0.5% | xxx |
Div Pay Ratio(%) | xxx | 50.6% | 47.3% | xxx |
Last ex-div: 03/03 - ex-div 10c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 29.6 |
DPS All | xxx | xxx | xxx | xxx | xxx | 15.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 67.9 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 78.4 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 39.0 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 45.45 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 43.49 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 42.36 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 27.89 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 43.49 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 57.75 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 25.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
PME STOCK CHART

FNArena News on PME
1 |
Australian Broker Call *Extra* Edition – Apr 13, 2022Apr 13 2022 - Daily Market Reports |
2 |
Rudi’s View: Peter’s Portfolio ReviewedApr 13 2022 - Rudi's View |
3 |
Rudi’s View: Too Many Distractions From Corporate ResultsMar 03 2022 - Rudi's View |
4 |
Rudi’s View: More Beats Than MissesFeb 24 2022 - Rudi's View |
5 |
Australian Broker Call *Extra* Edition – Feb 18, 2022Feb 18 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
1 |
Shortages Chip Away At ResMed’s Big BreakMar 30 2022 - Australia |
2 |
Opportunity for Fisher & Paykel HealthcareMar 25 2022 - Australia |
3 |
Distribution Anxiety For NanosonicsFeb 10 2022 - Australia |
4 |
Brokers Awake To ResMed’s PotentialJan 31 2022 - Australia |
5 |
Covid Benefits F&P Healthcare, For NowDec 06 2021 - Australia |
6 |
Will Shortages Limit Upside For ResMed?Nov 01 2021 - Australia |
7 |
Nanosonics Unveils Its New ProductAug 26 2021 - Australia |
8 |
Pro Medicus: Opportunity AwaitsAug 24 2021 - Technicals |
9 |
Breakout For CochlearAug 10 2021 - Technicals |
10 |
Will ResMed’s Market Share Gains Last?Aug 09 2021 - Australia |